SEARCH

Current Edition

BioNTech

With new trial, Pfizer and BioNTech will test whether an omicron vaccine is needed

Dive Brief: Pfizer and BioNTech have begun enrolling patients in a study testing a new version of their COVID-19 vaccine specifically tailored to the omicron …

Continue Reading →
booster

Moderna follows Pfizer in beginning trial of omicron vaccine

Dive Brief: Moderna on Wednesday said it has begun a trial testing a new version of its COVID-19 vaccine that’s tailored to the omicron variant, …

Continue Reading →
anxiety

M&A anxiety, Roche’s comeback plan and Vir’s omicron moment

The second day of the J.P. Morgan Healthcare Conference, much like the first, didn’t include the type of market-moving acquisitions or announcements that might break …

Continue Reading →
BioNTech

Omicron cuts Pfizer vaccine’s potency, but data show booster may restore protection

Three doses of Pfizer and BioNTech’s COVID-19 vaccine may protect against the new omicron variant similarly well as two doses did against the original coronavirus …

Continue Reading →
Antibody

Early tests suggest Vir, GSK antibody could hold up versus omicron

Omicron’s detection last week triggered travel restrictions and renewed public health measures around the world as scientists and government officials warned the variant may more …

Continue Reading →
Antibody

Regeneron warns its antibody drug may be less potent versus omicron

Regeneron’s drug is the top-selling COVID-19 treatment in the U.S., one of three antibody drugs currently authorized by the Food and Drug Administration for people …

Continue Reading →
coronavirus

Vaccine makers move quickly to confront omicron threat

Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant. Facing a coronavirus variant that experts …

Continue Reading →